Latest News

View allAccessAL amyloidosisCAR-TConferencesMPEMyelomaNewsPatient evidenceVideos

MPE launches the Myeloma and AL Amyloidosis European Clinical Trial Navigator

Brussels, 23 April 2024 – Myeloma Patients Europe (MPE) has launched today the English version of the Myeloma and AL Amyloidosis European Clinical Trial Navigator, an online search tool to learn about and find clinical trials for myeloma, monoclonal gammopathy of undetermined significance (MGUS), smouldering multiple myeloma (SMM) and AL amyloidosis in Europe. With this tool, MPE wants to facilitate the search…

Read more

MPE gives feedback on the proposed implementing act supporting the EU Health Technology Assessment regulation

The European Commission recently held an online public consultation on the first draft implementing act supporting the EU health technology assessment (HTA) regulation. The EU HTA regulation will be implemented from 2025 and aims to increase the collaboration on health technology assessment across EU member states. Implementing acts set out the legislative detail of different…

Read more

European Commission grants final approval for CAR-T treatment idecabtagene vicleucel (Abecma) in earlier lines of therapy for relapsed and refractory myeloma

The European Commission has granted the final approval for the extension of the marketing authorisation for idecabtagene vicleucel (ide-cel), a CAR-T treatment marketed by Bristol-Myers Squibb (BMS) as Abecma®. Ide-cel has previously been approved for the treatment of patients with relapsed and refractory myeloma, who have received at least three previous lines of therapy. The…

Read more

EMA CHMP gives positive recommendation on CAR T-cell therapy ciltacabtagene autoleucel in earlier lines of therapy for relapsed and refractory myeloma

The Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA – the EU medicines regulator) has today given a positive recommendation for the extension of the marketing authorisation for the CAR-T treatment ciltacabtagene autoleucel (Carvytki®), also known as cilta-cel, for use in patients who have received at least 1 prior…

Read more
April

May 2026

June
MO
TU
WE
TH
FR
SA
SU
27
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Events for 1st May
No Events
Events for 2nd May
No Events
Events for 3rd May
No Events
Events for 4th May
No Events
Events for 5th May
No Events
Events for 6th May
No Events
Events for 7th May
No Events
Events for 8th May
No Events
Events for 9th May
No Events
Events for 10th May
No Events
Events for 11th May
No Events
Events for 12th May
No Events
Events for 13th May
No Events
Events for 14th May
No Events
Events for 15th May
No Events
Events for 16th May
No Events
Events for 17th May
No Events
Events for 18th May
No Events
Events for 19th May
No Events
Events for 20th May
No Events
Events for 21st May
No Events
Events for 22nd May
No Events
Events for 23rd May
No Events
Events for 24th May
No Events
Events for 25th May
No Events
Events for 26th May
No Events
Events for 27th May
No Events
Events for 28th May
No Events
Events for 29th May
No Events
Events for 30th May
No Events
Events for 31st May
No Events